An experimental immunotherapy candidate targets toxic species of alpha-synuclein and was well tolerated in an ongoing, ...
Immatics (IMTX) has released an update. Immatics has reported promising updated Phase 1b clinical data for its ACTengine ...
1hon MSN
Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...
The drug is expected to offer nerve regeneration, potentially modifying the disease in diabetic peripheral neuropathy ...
Brakes For Breasts is different from any other breast cancer campaign: The Dr. Tuohy Lab is a team of researchers at the Cleveland Clinic has actually created a vaccine that has proved effective in ...
India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a ...
State-owned Uzbektelecom JSC (a.k.a. Uztelecom) and Internet Initiative Japan (IIJ) said on Thursday they will collaborate to ...
The company’s recent Phase 1b trial of VK-0214, an oral therapy for the treatment of X-linked adrenoleukodystrophy (X-ALD), demonstrated significant reductions in very long chain fatty acids (VLCFAs), ...
On Thursday, 2251 stocks advanced, 1663 declined and 132 remained unchanged, with an advance decline ratio 1.43 on the Bombay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback